Cumberland Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 02/18/2026 | 555.93 K | $2.21 M | 0.00% | 3.72% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 472.16 K | $1.88 M | -8.40% | 3.16% |
| VANGUARD GROUP INC | 01/29/2026 | 411.79 K | $1.64 M | 0.00% | 2.75% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 341.09 K | $1.36 M | 100.00% | 2.28% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 272.28 K | $1.08 M | -3.06% | 1.82% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 163.47 K | $650.60 K | -13.21% | 1.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 128.51 K | $511.46 K | -23.57% | 0.86% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 107.27 K | $427.01 K | 5.56% | 0.72% |
| J. GOLDMAN & CO LP | 02/17/2026 | 94.54 K | $376.27 K | -54.58% | 0.63% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 72.51 K | $288.60 K | 0.00% | 0.48% |
| BLACKROCK, INC. | 02/12/2026 | 52.58 K | $209.26 K | 0.86% | 0.35% |
| MARSHALL WACE, LLP | 02/13/2026 | 48.14 K | $191.59 K | 100.00% | 0.32% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 44.29 K | $176.00 K | 0.00% | 0.30% |
| STATE STREET CORP | 02/13/2026 | 33.70 K | $134.13 K | 0.00% | 0.23% |
| HERON BAY CAPITAL MANAGEMENT | 02/13/2026 | 29.19 K | $116.17 K | -7.82% | 0.20% |
| CITADEL ADVISORS LLC | 02/17/2026 | 29.00 K | $115.42 K | 36.15% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 26.04 K | $103.63 K | 100.00% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 24.49 K | $97.45 K | -34.86% | 0.16% |
| CITADEL ADVISORS LLC | 02/17/2026 | 21.96 K | $87.39 K | -47.02% | 0.15% |
| NORTHERN TRUST CORP | 02/17/2026 | 19.60 K | $78.02 K | 0.00% | 0.13% |
| CRESSET ASSET MANAGEMENT, LLC | 02/17/2026 | 17.48 K | $69.55 K | -5.41% | 0.12% |
| JANE STREET GROUP, LLC | 02/12/2026 | 15.50 K | $61.69 K | 100.00% | 0.10% |
| UBS GROUP AG | 01/29/2026 | 15.39 K | $61.24 K | 1,760.46% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 14.00 K | $55.72 K | 100.00% | 0.09% |
| CITADEL ADVISORS LLC | 02/17/2026 | 13.90 K | $55.32 K | 20.87% | 0.09% |
| MORGAN STANLEY | 02/13/2026 | 3.26 K | $12.98 K | -9.57% | 0.02% |
| NEWEDGE ADVISORS, LLC | 02/18/2026 | 1.20 K | $4.79 K | 59.13% | 0.01% |
| CAPITAL ADVISORS, LTD. LLC | 01/21/2026 | 437 | $2.00 K | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 200 | $796 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 9 | $36 | -47.06% | 0.00% |
| HUNTINGTON NATIONAL BANK | 02/09/2026 | 1 | $4 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 01/23/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cumberland Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of Cumberland Pharmaceuticals Inc.. The most heavily invested institutionals were:
DIMENSIONAL FUND ADVISORS LP: 276,359
Bank of New York Mellon Corp: 58,458
VANGUARD FIDUCIARY TRUST CO: 45,623
JANE STREET GROUP, LLC: 14,607
UBS Group AG: 5,189
Capital Advisors, Ltd. LLC: 437
19.78% of Cumberland Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.57 M shares in the last 24 months. This purchase volume represents approximately $12.19 M in transactions.